Certificate of participation with 1 CME is available
“Before oral cancer ever reaches an oncologist, it sits silently in a dental chair. The real question is are we even equipped to see it?”
We will be remembered not for the restorations we placed, but for the cancers we prevented when we had the chance to see them early. Oral cancer does not need better awareness. It needs dentists who choose to act while biology is still reversible. The future of dentistry is no longer confined to teeth. It lives in the biology we intercept, the lives we protect, and the responsibility we finally accept.
OralBlu Theranostics introduces a new clinical framework that enables dentists to detect and intercept these changes at a biological stage using intraoral photonic diagnostics integrated with targeted photomedicine.
This webinar explores how chairside fluorescence-based screening can transform routine dental visits into proactive oral cancer interception encounters. Beyond its clinical impact, this approach allows dental practices to implement scalable mass-screening models that enhance patient trust, elevate clinical relevance, and create new, ethical revenue streams without disrupting existing workflows.
Key Learning Objectives
* Understand how OralBlu Theranostics enables early biological detection beyond white-light examination
* Learn how intraoral photonic screening can be integrated into routine workflows for mass oral cancer interception
* Explore how structured screening protocols can ethically expand clinical revenue while improving patient outcomes
Date: 31/01/2026 | 07:00 PM IST
OConnor - 7 months ago